NCT01787526View on ClinicalTrials.gov

Intravenous High Dose Iron in Blood Donors

PHASE3CompletedINTERVENTIONAL
Enrollment

176

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Iron Deficiency
Interventions
DRUG

ferric carboxymaltose

1 g intravenously per infusion

DRUG

oral iron

oral tablets of 100mg iron over 8 weeks, total dose 10g

Trial Locations (1)

8036

Medical University of Graz, Graz

All Listed Sponsors
lead

Medical University of Graz

OTHER

NCT01787526 - Intravenous High Dose Iron in Blood Donors | Biotech Hunter | Biotech Hunter